Asthma Spacers Market Size, Share, and Industry Analysis, By Type (OTC, Prescription), By Application (Hospital Pharmacies, Retail Pharmacies, E-commerce) Regional Forecast (2022-2028)

REPORT OVERVIEW

• 
• Request Free Sample PDF to learn more about this report

The global asthma spacers market size was USD 1.184 billion in 2021. The global COVID-19 pandemic has been unprecedented and staggering, with experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. As per our research, the market is projected to touch USD 1.510 billion by 2028, exhibiting a CAGR of 3.1% during the projected period. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Asthma is a long-term issue that impacts all children and adults. Asthma occurs when the airspace in the respiratory system become constricted because of inflammation and stiffness of the muscles surrounding the airways. Asthma symptoms include shortness of breath, coughing, chest tightness, and wheezing. A tube-shaped clutching chamber is what an asthma spacer is. The spacers help to direct the medication to the airways, going to result in much less painkiller or drug in the throat and oral cavity. When employing a puffer renowned as a metered-dose inhaler, the asthma spacers is incredibly helpful (MDI). A spacer facilitates the administration of aerosolized medication. Often these spacers have just a one-way nozzle that enables the user to breathe the painkillers while ordinarily inhaling and exhaling.

COVID-19 Impact: Supply and Lockdown Limitations to Impede Market Advancement

Coronavirus has had a negative impact on the growth of many businesses, including the industries of pharmaceuticals and healthcare. Regional governments around the world levied shutdown, causing business owners to see a reduction in the demand for the medical equipment in the second and third quarters of 2020.

The most recent outbreak is the coronavirus (COVID-19) pandemic, which first revealed in Wuhan, China. The coronavirus pandemic and shutdown in various countries around the world has had a financial impact on businesses of all sizes. The health sector is one of those that has been greatly affected by the pandemic. The financial strain mostly on private health sector has increased as a result of the shutdown in different countries. Healthcare providers faced challenges in terms of workforce, hardware, essential items, and many other assets to ensure the security of patients with some other diseases, as well as declining outpatient visits.

LATEST TRENDS 

"Rising Environmental Pollution to Stimulate Market Development "

The global market for the machine is expected to grow due to rising air pollution, which causes a variety of respiratory diseases including asthma. Environmental allergic reactions and impurities, which include indoor and outdoor pollution, are thought to increase the likelihood of asthma. For example, according to the United States Environmental Protection Agency in October 2018, air quality can exasperate asthma symptoms and trigger asthma attacks. Asthma is a severe and possibly fatal severe respiratory disease that has an impact on the lives for over 23 million Americans.

The asthma spacers market growth is expected to grow at a rapid rate throughout the forecast period because of the rising environment pollution.

RESTRAINING FACTORS

"Availability of Alternative Treatment Methods to Hinder Market Advancement "

Alternative asthma treatment is a major factor impeding the expansion of the asthma spacer market over the forecast period. Bronchial thermoplasty can be used to treat asthma. It is a tried-and-true substitute asthma treatment. For example, Boston Scientific, a healthcare equipment developer, announced in May 2017 that patients who were treated with the Alair BT System, had yielded positive results. According to the findings, BT lowered abnormalities in elderly patients who had severe persistent asthma.

During the anticipated period, the asthma spacers market share is anticipated to be hindered by alternative method available in the market to cure the disease.

SEGMENTATION

• 
• Request Free Sample PDF to learn more about this report

• By Type

Based on type; the market is divided OTC, prescription

OTC type is the leading part of the type segment.

• By Application

Based on the application; the market is divided into hospital pharmacies, retail pharmacies, E-commerce

Hospital pharmacies is the leading part of the application segment.

DRIVING FACTORS

"Controllable Features of the Machine to Aid Market Expansion"

The main benefit of an inhaler spacer or asthma spacers is that it allows the patient to control how much medication he can take. This ensures that the patient not only get the predetermined limit, but that the patient inhale it in a manner that is comfortable for him. Ordinary asthma spacers require one to press a button to release the medication and then immediately take a deep breath. This rapid succession of actions can be difficult for some people. One doesn’t have to rush for the medication intake with a spacer. If a patient breathes in too quickly, some spacers will even make a small whistle sound. Furthermore, aero chamber technological advancements are expected to strengthen the section during the forecast timeframe.  Due to an increase in over-the-counter revenues of the instrument that include metered dose inhalers, the drug store type is expected to dominate a considerable share of the worldwide market.

"Increasing Incidence of Respiratory Diseases to Foster Industry Progress "

The machine demand is increasing due to an increase in the incidence of respiratory illnesses, that can be credited as a main driving factor in the expansion of the global market. Numerous factors, which include allergic conditions like eczema as well as rhinitis (hay fever), rapid urbanisation, tobacco smoke exposure, and viral respiratory problems, have been linked to a higher likelihood of developing asthma. According to the WHO (World Health Organization), asthma affected approximately 262 million people in 2019 and ended up causing approximately 461,000 fatal accidents. Furthermore, thus according Asthma U.K., there have been 77,124 hospitalizations for asthma in 2017, one person experiences a potentially serious asthma attack every 10 seconds.

REGIONAL INSIGHTS

• 
• Request Free Sample PDF to learn more about this report

"Rapid Advancements in the Model and Low Cost to Foster Market Advancement in Asia Pacific "

Asia Pacific is expected to account for a sizable portion of the machine market. Popularity from end-use industries like the healthcare will most likely increase over the projected timeframe. The advantages and utilisation of using best quality and reliable asthma spacers are anticipated to provide a boost to the economic expansion of the asthma spacers market share in Asia Pacific during the projected timeframe. Asia Pacific accounts for nearly one-fourth of machines market sales. Demand for asthma spacers in these regions is being driven by high asthma prevalence, favourable reimbursement policies, and an increase in government initiatives mandating the utilization of asthma spacers that include metered dose inhalers.

During the forecast period, the Asia Pacific market is expected to grow at a significant CAGR. A large asthmatic group with moderate to severe symptoms, as well as an increase in health-care spending, are predicted to drive the region's market over the next few years. Furthermore, the minimal rates of production in China and India will result in rise in the demand for the machines across the region.

KEY INDUSTRY PLAYERS

"Notable Players in the Industry to Promote Market Expansion "

The industry's growth was significantly influenced by the tactics employed by market participants in recent years, such as extensions. The report provides details and information on the companies and their interactions with the market. The data is gathered and published through appropriate research, technological advancements, expansions, and expanding machinery and equipment. Other criteria considered for this market are the firms that develop and provide new products, the areas in which they operate, mechanisation, innovative techniques, making the most money, and using their products to have a large social impact. This analysis examines the global and regional effects of the outbreak mostly on asthma spacers market. The study describes the asthma spacers market size features, and market growth by type, industry, and customer sector. Furthermore, it presents a complete examination of commercialization factors prior to and following the Covid-19 pandemic.

List of Market Players Profiled 

• GSK (U.K.)
• Clement Clarke International (U.K.)
• Monaghan Medical Corporation (U.S.)
• Medical Developments International (Australia)
• Teleflex (U.S.)
• Philips (Netherland)
• Drive Medical (New York)
• Smith’s Medical (U.S.)
• PARI (U.S.)
• Lupin (Mumbai)
• Pankajakasthuri Herbals (Kerela)
• Bird HealthCare (Australia)
• Respiratory Delivery Systems (U.S.)
• SunMed (U.S.)
• Cipla (Mumbai)
• Instrumentation Industries (U.S.)

REPORT COVERAGE

The industry report examines the global market, geographic and country-level market sizes, categorization market expansion, market share, competitor analysis, sales trends, influence of domestic and international market players, supply chain enhancement, trade laws, latest developments, possibilities analysis, business strategy market expansion analysis, product releases, area competitive landscape expanding, and technological advancements.